Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID DTD0392 Transporter Info
Gene Name SLC51B
Transporter Name Organic solute transporter subunit beta
Gene ID
123264
UniProt ID
Q86UW2
Post-Translational Modification of This DT
Overview of SLC51B Modification Sites with Functional and Structural Information
Sequence
PTM type
X-Phosphorylation X-Ubiquitination X: Amino Acid

Phosphorylation

  Serine

           2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

 Have the potential to influence SLC51B [1] , [2]

Role of PTM

 Potential impacts

Modified Residue

 Serine

Modified Location

 88

Experimental Method

 Co-Immunoprecipitation

Detailed Description

 Phosphorylation at SLC51B Serine 88 has the potential to affect its expression or activity.

  PTM Phenomenon 2

 Have the potential to influence SLC51B [3]

Role of PTM

 Potential impacts

Modified Residue

 Serine

Modified Location

 98

Experimental Method

 Co-Immunoprecipitation

Detailed Description

 Phosphorylation at SLC51B Serine 98 has the potential to affect its expression or activity.

  Threonine

           1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

 Have the potential to influence SLC51B [4]

Role of PTM

 Potential impacts

Modified Residue

 Threonine

Modified Location

 74

Experimental Method

 Co-Immunoprecipitation

Detailed Description

 Phosphorylation at SLC51B Threonine 74 has the potential to affect its expression or activity.

Ubiquitination

  Lysine

           2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

 Have the potential to influence SLC51B [5]

Role of PTM

 Potential impacts

Modified Residue

 Lysine

Modified Location

 100

Experimental Method

 Co-Immunoprecipitation

Detailed Description

 Ubiquitination at SLC51B Lysine 100 has the potential to affect its expression or activity.

  PTM Phenomenon 2

 Have the potential to influence SLC51B [5]

Role of PTM

 Potential impacts

Modified Residue

 Lysine

Modified Location

 111

Experimental Method

 Co-Immunoprecipitation

Detailed Description

 Ubiquitination at SLC51B Lysine 111 has the potential to affect its expression or activity.
References
1 Identification of Missing Proteins in the Phosphoproteome of Kidney Cancer. J Proteome Res. 2017 Dec 1;16(12):4364-4373.
2 Integrated analysis of global proteome, phosphoproteome, and glycoproteome enables complementary interpretation of disease-related protein networks. Sci Rep. 2015 Dec 11;5:18189.
3 Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
4 iTRAQ labeling is superior to mTRAQ for quantitative global proteomics and phosphoproteomics. Mol Cell Proteomics. 2012 Jun;11(6):M111.014423.
5 Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. Nature. 2021 Jun;594(7862):246-252.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.